{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:33:12Z","timestamp":1784255592826,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migraine is one of the most prevalent and disabling medical diseases in the world. The periaqueductal gray matter and the red nucleus play an important role in its pathogenesis. Our aim was to evaluate the echogenicity of the periaqueductal gray matter and the red nucleus in patients with migraine, by means of transcranial ultrasound.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, a group of patients with migraine (according to the International Classification of Headache Disorders) and a group of control subjects with comparable age-and-sex distribution were prospectively included. We evaluated the area and echogenicity of the periaqueductal gray matter and the red nucleus by means of transcranial ultrasound, both bedside and posteriorly analyzed with the medical image viewer Horos.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 115 subjects: 65 patients with migraine (39 of them with chronic migraine and 26 with episodic migraine), and 50 controls. Median disease duration in patients with chronic migraine was 29 (IQR: 19; 40) years, with a median of 18 (IQR: 14; 27) days of migraine per month. The area of the periaqueductal gray matter was larger in patients with chronic migraine compared to episodic migraine and controls (0.15[95%CI 0.12;0.22]cm\n                      <jats:sup>2<\/jats:sup>\n                      ; 0.11[95%CI 0.10;0.14]cm\n                      <jats:sup>2<\/jats:sup>\n                      and 0.12[95%CI 0.09;0.15]cm\n                      <jats:sup>2<\/jats:sup>\n                      , respectively;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043). Chronic migraine patients showed an intensity of the periaqueductal gray matter echogenicity lower than controls (90.57[95%CI 70.87;117.26] vs 109.56[95%CI 83.30;122.64];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.035). The coefficient of variation of periaqueductal gray matter echogenicity was the highest in chronic migraine patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009). No differences were observed regarding the area or intensity of red nucleus echogenicity among groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with chronic migraine showed a larger area of echogenicity of periaqueductal gray matter, a lower intensity of its echogenicity and a higher heterogenicity within this brainstem structure compared to patients with episodic migraine and controls. The echogenicity of the periaqueductal gray matter should be further investigated as a biomarker of migraine chronification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-023-01576-3","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T06:08:30Z","timestamp":1681711710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Periaqueductal gray matter echogenicity as a marker of migraine chronification: a case control study"],"prefix":"10.1186","volume":"24","author":[{"given":"Dolores","family":"Vilas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Ispierto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Hern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00ed","family":"Par\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"1576_CR1","first-page":"954","volume":"17","author":"Global Burden of Disease","year":"2016","unstructured":"Global Burden of Disease (2016) Collaborators (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:954\u2013976","journal-title":"Lancet Neurol"},{"issue":"1","key":"1576_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","journal-title":"Cephalalgia"},{"key":"1576_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factores, mechanisms and treatment. Nat Rev Neurol 12:455\u2013464","journal-title":"Nat Rev Neurol"},{"key":"1576_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamong M, Freitag F, Reed ML, Stewart WF (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343\u2013349","journal-title":"Neurology"},{"key":"1576_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitwz MA (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18:795\u2013804","journal-title":"Lancet Neurol"},{"key":"1576_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2021.812209","volume":"2","author":"E Mills","year":"2021","unstructured":"Mills E, Keay KA, Henderson LA (2021) Brainstem pain-modulation circuitry and its plasticity in neuropathic pain: insights from human brain imaging investigations. Front Pain Res 2:812209","journal-title":"Front Pain Res"},{"key":"1576_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00429-020-02171-x","volume":"226","author":"GA Basile","year":"2021","unstructured":"Basile GA, Quartu M, Bertino S, Serra MP, Boi M, Bramanti A, Anastasi GP, MIlardiCacciola DA (2021) Red nucleus structure and function: from anatomy to clinical neurosciences. Brain Struct Funct 226:69\u201391","journal-title":"Brain Struct Funct"},{"key":"1576_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1468-2982.2008.01723.x","volume":"29","author":"MC Kruit","year":"2009","unstructured":"Kruit MC, Overbosch J, van Buchem MA, Ferrari MD (2009) Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia 29:351\u2013359","journal-title":"Cephalalgia"},{"key":"1576_CR9","doi-asserted-by":"publisher","first-page":"e1076","DOI":"10.1212\/WNL.0000000000007047","volume":"92","author":"C Dominguez","year":"2019","unstructured":"Dominguez C, Lopez A, Ramos-Cabrer P, Vieites-Prado A, Perez-Mato M, Villalba C, Sobrino T, Rodriguez-Osorio X, Campos F, Castillo J, Leira R (2019) Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine. Neurology 92:e1076\u2013e1085","journal-title":"Neurology"},{"key":"1576_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/head.12774","volume":"56","author":"DW Dodick","year":"2016","unstructured":"Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB (2016) Assessing barriers to chronic migraine consultation, diagnosis, and treatment: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache 56:821\u2013834","journal-title":"Headache"},{"key":"1576_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/head.12174","volume":"53","author":"P Durham","year":"2013","unstructured":"Durham P, Papapetropoulos S (2013) Biomarkers associated with migraine and their potential role in migraine management. Headache 53:1262\u20131277","journal-title":"Headache"},{"key":"1576_CR12","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00415-015-7745-0","volume":"262","author":"D Vilas","year":"2015","unstructured":"Vilas D, Iranzo A, Pont-Sunyer C, Serradell M, Gaig C, Santamaria J, Tolosa E (2015) Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression. J Neurol 262:1665\u20131672","journal-title":"J Neurol"},{"key":"1576_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.parkreldis.2015.08.007","volume":"21","author":"D Vilas","year":"2015","unstructured":"Vilas D, Ispierto L, \u00c1lvarez R, Pont-Sunyer C, Mart\u00ed MJ, Valldeoriola F, Compta Y, de Fabregues O, Hern\u00e1ndez-Vara J, Puente V, Calopa M, Jaum\u00e0 S, Campdelacreu J, Aguilar M, Qu\u00edlez P, Casquero P, Lome\u00f1a F, R\u00edos J, Tolosa E (2015) Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers. Parkinsonism Relat Disord 21:1170\u20131176","journal-title":"Parkinsonism Relat Disord"},{"key":"1576_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","volume":"19","author":"WF Stewart","year":"1999","unstructured":"Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19:107\u2013114","journal-title":"Cephalalgia"},{"key":"1576_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB, Ware JE, Garber WH, Batenhorst A, Cady R, Dahl\u00f6f CGH, Dowson A, Tepper S (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12:963\u2013974","journal-title":"Qual Life Res"},{"key":"1576_CR16","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s11136-007-9217-1","volume":"16","author":"JC Cole","year":"2007","unstructured":"Cole JC, Lin P, Rupnow MFT (2007) Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment. Qual Life Res 16:1231\u20131237","journal-title":"Qual Life Res"},{"key":"1576_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"1576_CR18","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(08)70239-4","volume":"7","author":"D Berg","year":"2008","unstructured":"Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044\u20131055","journal-title":"Lancet Neurol"},{"key":"1576_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10194-019-1011-2","volume":"20","author":"W Tao","year":"2019","unstructured":"Tao W, Cai X, Shen J, Xue-Gong S, Wang Y (2019) Hypoechogenicity of brainstem raphe correlates with depression in migraine patients. J Headache Pain 20:53","journal-title":"J Headache Pain"},{"key":"1576_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1046\/j.1526-4610.2001.041007629.x","volume":"41","author":"KM Welch","year":"2001","unstructured":"Welch KM et al (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629\u2013637","journal-title":"Headache"},{"key":"1576_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26583","author":"R Messina","year":"2022","unstructured":"Messina R, Sudre CH, Wei DY, Filippi M, Ourselin S, Goadsby PJ (2022) Biomarkers of Migraine and Cluster Headache: Differences and Similarities. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.26583","journal-title":"Ann Neurol"},{"key":"1576_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jon.13070","author":"L Dorado","year":"2022","unstructured":"Dorado L, Rubio-Guerra S, Valls-Carb\u00f3 A, Ispierto L, Hern\u00e1ndez-P\u00e9rez M, Par\u00e9 M, Vilas D (2022) Hypoechogenicity of the raphe nuclei as a biomarker of migraine: A case-control study, review, and meta-analysis. J Neuroimaging. https:\/\/doi.org\/10.1111\/jon.13070","journal-title":"J Neuroimaging"},{"key":"1576_CR23","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/0333102415617415","volume":"36","author":"I Ayzenberg","year":"2016","unstructured":"Ayzenberg I, Nastos I, Strassburger-Krogias K, Obermann M, Gold R, Krogias C (2016) Hypoechogenicity of brainstem raphe nuclei is associated with increased attack frequency in episodic migraine. Cephalalgia 36:800\u2013806","journal-title":"Cephalalgia"},{"key":"1576_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0333102416665225","volume":"37","author":"G Hamerla","year":"2017","unstructured":"Hamerla G, Kropp P, Meyer B, Rocco A, J\u00dcrgensWalter U (2017) Midbrain raphe hypoechogenicity in migraineurs: an indicator for the use of analgesics but not triptans. Cephalalgia 37:1057\u20131066","journal-title":"Cephalalgia"},{"key":"1576_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10194-019-1011-2","volume":"20","author":"W Tao","year":"2019","unstructured":"Tao W, Cai X, Shen J, Shi XG, Wang Y (2019) Hypoechogenicity of brainstem raphe correlates with depression in migraine patients. J Headache Pain 20:53","journal-title":"J Headache Pain"},{"key":"1576_CR26","doi-asserted-by":"publisher","first-page":"175628642110077","DOI":"10.1177\/17562864211007708","volume":"14","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu Y, Han R, Liu K, Xing Y (2021) Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients. Ther Adv Neurol Disord 14:17562864211007708","journal-title":"Ther Adv Neurol Disord"},{"key":"1576_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0301-5629(99)00046-0","volume":"25","author":"D Berg","year":"1999","unstructured":"Berg D, Grote C, Rausch M, Wesemann W, Riederer P, Becker G (1999) Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 25:901\u2013904","journal-title":"Ultrasound Med Biol"},{"key":"1576_CR28","doi-asserted-by":"publisher","first-page":"A61","DOI":"10.1186\/1129-2377-16-S1-A61","volume":"16","author":"E Guaschino","year":"2015","unstructured":"Guaschino E, Ghiotto N, Tassorelli C, Bitetto V, Nappi G, Moglia A, Bosone D, Sances G (2015) Hyperechogenicity of the periaqueductal gray in chronic migraine and episodic migraine as a potential marker of progressive dysfunction: preliminary results with transcranial sonography. J Headache Pain 16:A61","journal-title":"J Headache Pain"},{"key":"1576_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archneur.59.6.999","volume":"59","author":"D Berg","year":"2002","unstructured":"Berg D, Roggendorf W, Schr.derKleinTatschner URT, BenzTucha PO, Preier M, LangeReiners KWK, GerlachBecker MG (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999\u20131005","journal-title":"Arch Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01576-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T06:08:33Z","timestamp":1681711713000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01576-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1576"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01576-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2727831\/v1","asserted-by":"object"}]},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of Hospital Germans Trias i Pujol (PI-20\u2013081). All subjects signed the informed consent form for participation in the study and use of their clinical data for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}